ArriVent BioPharma, Inc. Common Stock (AVBP)
PHARMACEUTICAL PREPARATIONS
ArriVent BioPharma, Inc. Common Stock (AVBP) is listed on Nasdaq, where it has traded since January 26, 2024.
- Listed On
- Nasdaq
- Listed Since
- January 26, 2024
- Employees
- 77
- Market Cap
- $776M
About ArriVent BioPharma, Inc. Common Stock
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 150 institutions reported holding AVBP, with 46.0 million shares worth $1.6 billion in aggregate. The largest reported holder was Suvretta Capital Management, with 4.5 million shares worth $156.9 million. Of the 5 largest holders listed below, 3 added shares and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Suvretta Capital Management | 4,515,531 | $157M | Added 2.6% |
| Infinitum Asset Management | 4,438,384 | $154M | Added 6.98% |
| Hhlr Advisors, Ltd | 3,929,117 | $136M | Unchanged |
| BlackRock | 3,250,396 | $113M | Added 28.46% |
| Orbimed Advisors | 3,027,328 | $105M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AVBP?
ArriVent BioPharma, Inc. Common Stock (AVBP) is listed on Nasdaq, where it has traded since January 26, 2024.
Who are the largest institutional holders of AVBP?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AVBP were Suvretta Capital Management, Infinitum Asset Management and Hhlr Advisors, Ltd.
How many institutions own AVBP?
150 institutions reported a position in AVBP for the quarter ended June 30, 2026, worth $1.6 billion in total.
Did institutions buy or sell AVBP last quarter?
Of the 5 largest reported holders, 3 added shares and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for AVBP.
Every reported institutional holder, plus insider and congressional trades in AVBP, on SentiSense.